日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states

MPS-Authors

Panzeri,  Ilaria
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Dror,  Erez
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons198873

Pospisilik,  John Andrew
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

10.1038_s43018-024-00900-3.pdf
(出版社版), 19MB

付随資料 (公開)
There is no public supplementary material available
引用

Panzeri, I., Fagnocchi, L., Apostle, S., Tompkins, M., Wolfrum, E., Madaj, Z., Hostetter, G., Liu, Y., Schaefer, K., Yang, C.-H., Bergsma, A., Drougard, A., Dror, E., PERMUTE, Chandler, D. P., Schramek, D., Triche Jr, T. J., & Pospisilik, J. A. (2025). TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states. Nature cancer, 6, 385-403. doi:10.1038/s43018-024-00900-3.


引用: https://hdl.handle.net/21.11116/0000-0010-CB1B-C
要旨
Mutations in cancer risk genes increase susceptibility, but not all carriers develop cancer. Indeed, while DNA mutations are necessary drivers of cancer, only a small subset of mutated cells go on to cause the disease. To date, the mechanisms underlying individual cancer susceptibility remain unclear. Here, we took advantage of a unique mouse model of intrinsic developmental heterogeneity (Trim28+/D9) to investigate whether early-life epigenetic variation influences cancer susceptibility later in life. We found that heterozygosity of Trim28 is sufficient to generate two distinct early-life epigenetic states associated with differing cancer susceptibility. These developmentally primed states exhibit differential methylation patterns at typically silenced heterochromatin, detectable as early as 10 days of age. The differentially methylated loci are enriched for genes with known oncogenic potential, frequently mutated in human cancers and correlated with poor prognosis. This study provides genetic evidence that intrinsic developmental heterogeneity can prime individual, lifelong cancer susceptibility.